AU8202198A - Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan - Google Patents

Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan

Info

Publication number
AU8202198A
AU8202198A AU82021/98A AU8202198A AU8202198A AU 8202198 A AU8202198 A AU 8202198A AU 82021/98 A AU82021/98 A AU 82021/98A AU 8202198 A AU8202198 A AU 8202198A AU 8202198 A AU8202198 A AU 8202198A
Authority
AU
Australia
Prior art keywords
hyaluronan
pharmaceutical compositions
angiostatic steroid
combined
steroid combined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU82021/98A
Inventor
Chandan Alam
Michael P. Seed
Derek A Willoughby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hyal Pharmaceutical Corp
Original Assignee
Hyal Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyal Pharmaceutical Corp filed Critical Hyal Pharmaceutical Corp
Publication of AU8202198A publication Critical patent/AU8202198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU82021/98A 1997-07-03 1998-07-03 Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan Abandoned AU8202198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002208916A CA2208916A1 (en) 1997-07-03 1997-07-03 Promotion of wound healing utilizing steroids having reduced deterioroussystemic side effects typical of glucocorticoids, mineralocorticoids andsex steroids
CA2208916 1997-07-03
PCT/CA1998/000649 WO1999001142A1 (en) 1997-07-03 1998-07-03 Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan

Publications (1)

Publication Number Publication Date
AU8202198A true AU8202198A (en) 1999-01-25

Family

ID=4160953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU82021/98A Abandoned AU8202198A (en) 1997-07-03 1998-07-03 Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan

Country Status (3)

Country Link
AU (1) AU8202198A (en)
CA (1) CA2208916A1 (en)
WO (1) WO1999001142A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
AU8838601A (en) * 2000-11-27 2002-06-03 Entremed Inc Antiangiogenic agents
US7498322B2 (en) 2004-03-12 2009-03-03 Entremed, Inc. Antiangiogenic agents
CA2646065C (en) 2006-03-20 2014-01-14 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
FR2918892B1 (en) * 2007-07-16 2010-02-12 Fabre Pierre Dermo Cosmetique ANTI-INFLAMMATORY DERMATOLOGICAL COMPOSITION COMPRISING CORTICIDES AND HYALURONATE FRAGMENTS, AND USES THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
WO1990015816A1 (en) * 1989-06-16 1990-12-27 The Upjohn Company Suramin type compounds and angiostatic steroids to inhibit angiogenesis

Also Published As

Publication number Publication date
CA2208916A1 (en) 1999-01-03
WO1999001142A1 (en) 1999-01-14

Similar Documents

Publication Publication Date Title
AU4762797A (en) Pharmaceutical compositions
AU6216296A (en) Pharmaceutical compositions
AU6513298A (en) Therapeutic compositions
AU6740298A (en) Pharmaceutical composition
AU2967597A (en) Pharmaceutical compositions
AU3192700A (en) Medicinal compositions
AU3556400A (en) Pharmaceutical compositions
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU4328800A (en) Pharmaceutical formulation
AU1306997A (en) Pharmaceutical compositions with vitamin d analogues
AU8747998A (en) Anti-inflammatory agent
AU8202198A (en) Pharmaceutical compositions comprising an angiostatic steroid combined with a hyaluronan
AU5274096A (en) Pharmaceutical compositions
AU9343098A (en) Pharmaceutical composition
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU3460897A (en) Medicinal compositions
AU6460200A (en) Pharmaceutical compositions
AU4636396A (en) Antiglucocorticoid medicament
AUPP332898A0 (en) Pharmaceutical composition
AU4326197A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions
AU3839900A (en) Pharmaceutical formulation
AU5296799A (en) Pharmaceutical compositions against autoimmune diseases
AUPN862596A0 (en) Pharmaceutical compositions